ClinicalTrials.gov
public full text
Public Domain
A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy
A study to evaluate safety and activity in treatment of IgAN patients using Rituximab in combination with RASi(ACEI and/or ARB) compared with RASi.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mediators of Loin Pain in IgA Nephropathy#852002
- Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy#881571
- Efficacy and Safety of Atacicept in IgA Nephropathy#855252
- An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma#807799
- Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy#1126391
Record · ID 1033570
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive